Skip to main content

Want a detailed portfolio tracker?

Polyrizon (PLRZ) P/E (2024 - 2026)

Polyrizon (PLRZ) P/E from Oct 29, 2024 to Jun 2, 2026. The TTM Polyrizon (PLRZ) P/E is -6.80. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Polyrizon (PLRZ)

YearP/EChange
2026-6.80+65.96%
2025-4.10-99.82%
2024-2.31KN/A

Comparison Polyrizon (PLRZ) P/E with competitors

Polyrizon (PLRZ) P/E is -6.80.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.50%
ENLVEnlivex Therapeutics Ltd0.15-102.21%
FGENFibroGen Inc0.24-103.53%
TRAWTraws Pharma Inc0.47-106.95%
FBIOFortress Biotech Inc0.71-110.37%
CHRSCoherus Biosciences Inc0.98-114.37%
ORMPOramed Pharmaceuticals Inc1.47-121.65%
AGENAgenus Inc2.05-130.10%
VIVSVivoSim Labs Inc2.54-137.26%
INVAInnoviva Inc3.19-146.85%
CRMDCorMedix Inc3.65-153.57%
ABEOAbeona Therapeutics Inc4.20-161.79%
VXRTVaxart Inc4.26-162.62%
CVACCureVac N.V.4.45-165.33%
SRPTSarepta Therapeutics Inc4.62-167.95%
GLPGGalapagos NV4.86-171.40%
RIGLRigel Pharmaceuticals4.92-172.29%
ZVRAZevra Therapeutics Inc4.97-173.09%
ABUSArbutus Biopharma Corp5.69-183.67%
CGENCompugen Ltd7.38-208.51%
AUPHAurinia Pharmaceuticals Inc9.25-235.95%
ACADAcadia Pharmaceuticals Inc9.59-240.90%
OMEROmeros Corporation9.88-245.24%
PLXProtalix BioTherapeutics Inc9.91-245.61%
SPROSpero Therapeutics Inc10.73-257.75%
ADMAAdma Biologics Inc11.33-266.50%
SVASinovac Biotech Ltd11.44-268.05%
TBPHTheravance Biopharma Inc11.78-273.06%
HRMYHarmony Biosciences Holdings Inc12.18-278.99%
TGTXTG Therapeutics Inc13.18-293.67%
INCYIncyte Corp13.38-296.65%
SABSSAB Biotherapeutics Inc14.06-306.58%
XOMAXOMA Corp14.95-319.62%
REGNRegeneron Pharmaceuticals Inc14.98-320.14%
PBYIPuma Biotechnology Inc15.05-321.17%
EXELExelixis Inc15.79-332.11%
NAGENiagen Bioscience Inc16.35-340.34%
CPRXCatalyst Pharmaceuticals Inc17.34-354.88%
MDXGMimedx Group Inc17.38-355.33%
ARGXArgen X SE23.07-439.04%
HALOHalozyme Therapeutics Inc23.20-440.93%
XOMAOXOMA Corp25.34-472.44%
VRTXVertex Pharmaceuticals Inc25.66-477.01%
XOMAPXOMA Corp25.67-477.22%
CTMXCytomX Therapeutics Inc25.70-477.63%
ASNDAscendis Pharma A/S26.35-487.28%
RPRXRoyalty Pharma plc - Class A27.50-504.05%
SLNOSoleno Therapeutics Inc29.02-526.38%
LGNDLigand Pharmaceuticals Inc - Class B30.19-543.59%
BMRNBiomarin Pharmaceutical Inc37.51-651.17%
APLSApellis Pharmaceuticals Inc39.02-673.42%
KRYSKrystal Biotech Inc39.70-683.36%
GMABGenmab40.20-690.80%
ONCBeiGene Ltd67.03-1084.97%
TECHBio-Techne Corp68.59-1108.01%
VCELVericel Corp80.63-1284.85%
PHARPharming Group N.V.87.74-1389.35%
ALNYAlnylam Pharmaceuticals Inc124.93-1935.91%
TLXTelix Pharmaceuticals Ltd139.89-2155.71%
CORTCorcept Therapeutics Inc158.39-2427.55%